Skip to content
Search

Latest Stories

Brexit: NPA welcomes 'common sense' approach to Northern Ireland medicines changes

The National Pharmacy Association has welcomed Cabinet Office's announcement of a phased process for implementing medicines regulation in Northern Ireland up to December 31.

The UK government and the European Commission reached an agreement during the fourth meeting of the Ireland/Northern Ireland Specialised Committee held virtually on November 5.


In a press statement issued by the Cabinet Office on Thursday (Nov 5), the government said the deal would allow businesses time prepare batch testing, importation and Falsified Medicines Directive requirements.

The NPA, which had been lobbying the Cabinet Office minister Michael Gove for a delay, said the announcement that a phased approach has now been agreed was "common sense".

In a letter sent to Gove on October 27, NPA chair Andrew Lane had written that the requirement for Northern Ireland to continue to comply with EU medicines regulations that would no longer apply in the UK could distort the medicines supply chain.

He had warned that the additional cost and complexity of getting medicines into Northern Ireland could result in medicines shortages and an increase in procurement costs. He had urged more time would be needed for planning and implementation.

Reacting to the latest announcement, Lane said on Monday (Nov 9): “This buys time for businesses to prepare in relation to batch testing, imports and the Falsified Medicines Directive. In the circumstances, it’s a common sense decision which we support. We believe our representations on behalf of NPA members in Northern Ireland have been on the mark, pragmatic and effective.”

Earlier in October, the UK Community Pharmacy Falsified Medicine Directive Working Group called on the government in Westminster to protect the supply of medicines into Northern Ireland following the end of the Brexit transition period.

The working group consists of the national organisations representing community pharmacy across the UK.

More For You

Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online

Kenalog® can cause serious mental health problems.

gettyimages

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

Patients are being urged to avoid buying unlicensed medications such as Kenalog® online to treat hay fever symptoms this spring, as pharmacists report a sharp rise in public interest in the drug.

The National Pharmacy Association (NPA), which represents over 6000 independent community pharmacies, has warned patients that buying medication from unregulated sellers, such as beauty salons and from social media sites, could serious health risks.

Keep ReadingShow less
The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less